Shares

15 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2024

May 13, 2024

BUY
$304.11 - $351.99 $2.46 Million - $2.85 Million
8,100 New
8,100 $2.8 Million
Q2 2023

Aug 09, 2023

BUY
$359.49 - $486.4 $1.4 Million - $1.9 Million
3,900 Added 18.75%
24,700 $9.36 Million
Q1 2023

May 12, 2023

SELL
$418.69 - $503.0 $2.34 Million - $2.82 Million
-5,600 Reduced 21.21%
20,800 $9.96 Million
Q4 2022

Feb 13, 2023

BUY
$351.71 - $456.01 $3.13 Million - $4.06 Million
8,900 Added 50.86%
26,400 $11.1 Million
Q3 2022

Nov 14, 2022

BUY
$412.59 - $563.26 $948,957 - $1.3 Million
2,300 Added 15.13%
17,500 $7.3 Million
Q2 2022

Aug 15, 2022

BUY
$463.67 - $597.16 $3.34 Million - $4.3 Million
7,200 Added 90.0%
15,200 $7.52 Million
Q4 2021

Feb 15, 2022

SELL
$708.84 - $794.68 $2.48 Million - $2.78 Million
-3,500 Reduced 30.43%
8,000 $6.05 Million
Q3 2021

Nov 12, 2021

BUY
$657.71 - $825.77 $328,855 - $412,885
500 Added 4.55%
11,500 $8.58 Million
Q2 2021

Aug 16, 2021

BUY
$576.64 - $649.04 $980,288 - $1.1 Million
1,700 Added 18.28%
11,000 $7.09 Million
Q1 2021

May 17, 2021

SELL
$547.01 - $662.35 $2.02 Million - $2.45 Million
-3,700 Reduced 28.46%
9,300 $5.31 Million
Q4 2020

Feb 12, 2021

SELL
$510.68 - $643.45 $663,884 - $836,485
-1,300 Reduced 9.09%
13,000 $7.58 Million
Q3 2020

Nov 12, 2020

SELL
$454.43 - $535.6 $1.68 Million - $1.98 Million
-3,700 Reduced 20.56%
14,300 $7.37 Million
Q2 2020

Aug 06, 2020

BUY
$334.87 - $493.06 $1.37 Million - $2.02 Million
4,100 Added 29.5%
18,000 $8.13 Million
Q1 2020

May 13, 2020

SELL
$320.01 - $409.07 $64,002 - $81,814
-200 Reduced 1.42%
13,900 $4.87 Million
Q4 2019

Feb 10, 2020

BUY
$319.73 - $374.2 $4.51 Million - $5.28 Million
14,100 New
14,100 $5.22 Million

Others Institutions Holding BIO

About BIO-RAD LABORATORIES, INC.


  • Ticker BIO
  • Exchange NYSE
  • Sector Healthcare
  • Industry Medical Devices
  • Shares Outstandng 24,633,900
  • Market Cap $8.37B
  • Description
  • Bio-Rad Laboratories, Inc. manufactures, and distributes life science research and clinical diagnostic products in the United States, Europe, Asia, Canada, and Latin America. The company operates through Life Science and Clinical Diagnostics segments. The Life Science segment develops, manufactures, and markets a range of reagents, apparatus, an...
More about BIO
Track This Portfolio

Track Andra Ap Fonden Portfolio

Follow Andra Ap Fonden and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Andra Ap Fonden, based on Form 13F filings with the SEC.

News

Stay updated on Andra Ap Fonden with notifications on news.